"Le pavillon Damien Delamaire, situé à l'Hôtel-Dieu, est une structure médico-sociale accueillant des personnes âgées en perte d’autonomie qui ne veulent ou ne peuvent plus rester à domicile. Il regroupe 120 lits d’établissement d’hébergement pour personnes âgées dépendantes (EHPAD), parmi lesquels 26 sont dédiés à la prise en charge de patients atteints de la maladie d’Alzheimer."

During the past decade, CHU RENNES - Hôpital Hôtel Dieu conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "CHU RENNES - Hôpital Hôtel Dieu" are "Age-Related Cognitive Decline" (1 trials), "Alzheimer's Disease" (1 trials) and "Memory Disorders" (1 trials). Many other conditions were trialed in "CHU RENNES - Hôpital Hôtel Dieu" in a lesser frequency.

Most popular intervention types in "CHU RENNES - Hôpital Hôtel Dieu" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Cholecalciferol 100 000 UI" (1 trials), "Donepezil" (1 trials), "Galantamine" (1 trials) and "Memantine" (1 trials). Other intervention names were less common.

The vast majority of trials in "CHU RENNES - Hôpital Hôtel Dieu" are 2 trials for "All" genders.

Currently, there are NaN active trials in "CHU RENNES - Hôpital Hôtel Dieu". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in CHU RENNES - Hôpital Hôtel Dieu, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CHU RENNES - Hôpital Hôtel Dieu, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".